http://ift.tt/eA8V8J
PLYMOUTH, Minn.–(BUSINESS WIRE)–Monteris Medical today announced the recent completion of a Series C financing, raising $26.6 million in new equity. Monteris Medical is a privately held leader in the market for minimally invasive, MRI-guided laser ablation systems for treating brain lesions. Monteris currently markets the NeuroBlate® System in the United States and Canada as a surgical tool that provides neurosurgeons an alternative to traditional craniotomies. The Series C financing was led
June 02, 2017 at 02:05AM
from
No comments:
Post a Comment